News

Stay up to date on our latest stories.

Filters

HIKMA wins Mitigare / Colchicine patent infringement case

Press Release, Corporate
HIKMA wins Mitigare / Colchicine patent infringement case

AGM Trading Update

Press Release, Corporate
AGM Trading Update

Hikma receives Drug Shortage Assistance Award from US FDA

Press Release, Product
Hikma receives Drug Shortage Assistance Award from US FDA

Hikma receives FDA approval for Leucovorin Calcium Injection

Press Release, Product
Hikma receives FDA approval for Leucovorin Calcium Injection

Hikma receives FDA approval for Fluphenazine Decanoate Injection

Press Release, Product
Hikma receives FDA approval for Fluphenazine Decanoate Injection

Hikma Pharmaceuticals Celebrates ninth annual global volunteering day

Press Release, Responsibility
Hikma Pharmaceuticals Celebrates ninth annual global volunteering day

Hikma’s ANDA for Generic Advair Diskus® accepted for filing by FDA

Press Release, Corporate
Hikma’s ANDA for Generic Advair Diskus® accepted for filing by FDA

Hikma’s ANDA for Generic Advair Diskus® accepted for filing by FDA (1)

Press Release, Product
Hikma’s ANDA for Generic Advair Diskus® accepted for filing by FDA (1)

Hikma receives FDA approval for Temozolomide Capsules

Press Release, Product
Hikma receives FDA approval for Temozolomide Capsules

Hikma Pharmaceuticals Preliminary Results

Press Release, Corporate
Hikma Pharmaceuticals Preliminary Results

Hikma receives FDA approval for Rifampin Injection

Press Release, Product
Hikma receives FDA approval for Rifampin Injection

Hikma receives FDA approval for Methylprednisolone Sodium Succinate Injection

Press Release, Product
Hikma receives FDA approval for Methylprednisolone Sodium Succinate Injection

Hikma receives FDA approval for Etomidate Injection

Press Release, Product
Hikma receives FDA approval for Etomidate Injection

Hikma receives FDA approval for Acyclovir Injection

Press Release, Product
Hikma receives FDA approval for Acyclovir Injection

Notice of Results (March 2016)

Press Release, Corporate
Notice of Results (March 2016)